From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING Scandal: The 16 other Innovate UK grants to Versarien exposed - what return has the taxpayer had on them? Nil!

By Tom Winnifrith, The Sheriff of AIM | Friday 28 August 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


As things stand, Versarien (VRShas drawn down the first 40% of a £5 million low interest loan from taxpayer-funded Innovate UK despite demonstrably being ineligible for what is the body’s biggest ever loan - indeed admitting in its own annual report that it breaches the eligibility criteria. That is a scandal. But I can now show why this scandal is far worse and suggests that Innovate UK hands out cash to favoured companies on an utterly indiscriminate and un-monitored manner which no assessment of whether its funding delivers any return or benefits for taxpayers. What follows is shocking. A co-conspirator has raised the issue of the illegitimate loan with Innovate UK and has this response from a Matthew Oswin:

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Sunday »

Quiz

The ShareProphets Sunday Pub Quiz #272

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:14:49